...
首页> 外文期刊>Psikiyatride Guncel Yaklasimlar: Current Approaches in Psychiatry >Tourette Bozuklu?unda ?la? Tedavisi [Pharmacological Treatment of Tourette Disorder]
【24h】

Tourette Bozuklu?unda ?la? Tedavisi [Pharmacological Treatment of Tourette Disorder]

机译:与Tourette ger抽动秽语障碍的药理治疗

获取原文

摘要

Tourette disorder is a chronic neuropsychiatric disorder characterized by vocal and motor tics. The course of the disorder shows waxing and vaning pattern and symptoms adversely affect patients’ quality of life. Patients use psychopharmacologic agents for long periods to control their symptoms during which they also struggle with drug related side effects. Clinicians face serious difficulties in controlling symptoms with psychopharmacological agents. Primarily alpha 2 receptor agonists and antipsychotic drugs have been used in the treatment of Tourette disorder. Risperidone and aripiprazole are the most commonly used new generation antipsychotics in the treatment. In addition there are contradictory findings regarding the use of dopamine agonists, tetrabenazine, topiramate, levatirasetame, and delta-9-tetrahydrocannabinol in these patients
机译:Tourette障碍是一种以发声和运动抽动为特征的慢性神经精神疾病。这种疾病的病程显示出蜡状和叶片状,症状对患者的生活质量产生不利影响。患者长期使用心理药物来控制其症状,在此期间他们还与药物相关的副作用作斗争。临床医生在用心理药物控制症状方面面临严重困难。主要将α2受体激动剂和抗精神病药用于治疗图雷特病。利培酮和阿立哌唑是治疗中最常用的新一代抗精神病药。此外,在这些患者中使用多巴胺激动剂,丁苯那嗪,托吡酯,左旋西美坦和δ-9-四氢大麻酚存在矛盾的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号